Patients with chronic kidney disease who took Vytorin, a cholesterol lowering pill, had one sixth fewer heart attacks, strokes or operations to unblock their arteries than patients taking a Placebo, according to the results of a study presented Saturday.
Vytorin helps people with kidney disease a study suggests.